Envista Holdings Corporation (NYSE: NVST) is a prominent player in the dental products industry, providing a wide range of solutions for dental professionals. The company operates in various segments, including orthodontics, implants, and digital imaging. Envista faces competition from other dental product companies like Dentsply Sirona and Align Technology.
On October 30, 2025, Jonathan Block from Stifel Nicolaus set a price target of $25 for NVST, which was trading at $20.37 at the time. This suggests a potential increase of approximately 22.73%. StreetInsider highlighted Stifel's reiterated buy rating on Envista, indicating confidence in the company's future performance.
Envista's third-quarter 2025 financial results show strong performance, with core growth, adjusted EBITDA, and adjusted EPS surpassing expectations. CEO Paul Keel emphasized the positive growth across all major business segments, particularly noting the profitability achieved with Spark aligners, as highlighted by PR Newswire.
Financially, Envista reported an operating cash flow of $79 million and a free cash flow of $68 million for the third quarter. These figures represent an increase from the previous year's $71 million and $63 million, respectively. The company also repurchased 2.1 million shares, amounting to approximately $41 million.
Currently, NVST is priced at $19.92, reflecting a slight decrease of 0.3% or $0.06. During the trading day, the stock fluctuated between a low of $19.89 and a high of $21.16. Over the past year, NVST has experienced a high of $23 and a low of $14.22. The company's market capitalization is approximately $3.31 billion, with a trading volume of 2,686,758 shares on the NYSE.
